Search hospitals > Florida > Fort Myers

Regional Cancer Center-Lee Memorial Health System

Claim this profile
Fort Myers, Florida 33905
Global Leader in Cancer
Conducts research for Tumors
Conducts research for Breast Cancer
Conducts research for Sarcoma
Conducts research for Lymphoma
70 reported clinical trials
6 medical researchers
Photo of Regional Cancer Center-Lee Memorial Health System in Fort MyersPhoto of Regional Cancer Center-Lee Memorial Health System in Fort MyersPhoto of Regional Cancer Center-Lee Memorial Health System in Fort Myers

Summary

Regional Cancer Center-Lee Memorial Health System is a medical facility located in Fort Myers, Florida. This center is recognized for care of Cancer, Tumors, Breast Cancer, Sarcoma, Lymphoma and other specialties. Regional Cancer Center-Lee Memorial Health System is involved with conducting 70 clinical trials across 129 conditions. There are 6 research doctors associated with this hospital, such as Paul M. Bloomston, Venkata K. Parsa, Edward Grendys, MD, and Leandro P. Moraes.

Area of expertise

1Cancer
Global Leader
Regional Cancer Center-Lee Memorial Health System has run 11 trials for Cancer. Some of their research focus areas include:
Stage III
Stage IV
Stage I
2Tumors
Regional Cancer Center-Lee Memorial Health System has run 10 trials for Tumors. Some of their research focus areas include:
Stage IV
Stage III
Ki-67 positive

Top PIs

Clinical Trials running at Regional Cancer Center-Lee Memorial Health System

Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Gallbladder Cancer
Pancreatic Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Ovarian Cancer
Small Intestinal Adenocarcinoma
Cancer
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Image of trial facility.

Genetic Testing

for Early-Stage Lung Cancer

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Regional Cancer Center-Lee Memorial Health System?
Regional Cancer Center-Lee Memorial Health System is a medical facility located in Fort Myers, Florida. This center is recognized for care of Cancer, Tumors, Breast Cancer, Sarcoma, Lymphoma and other specialties. Regional Cancer Center-Lee Memorial Health System is involved with conducting 70 clinical trials across 129 conditions. There are 6 research doctors associated with this hospital, such as Paul M. Bloomston, Venkata K. Parsa, Edward Grendys, MD, and Leandro P. Moraes.